Order Article Reprints

Hiltner T, Szörenyi N, Kohlruss M, Hapfelmeier A, Herz A-L, Slotta-Huspenina J, Jesinghaus M, Novotny A, Lange S, Ott K, et al. Significant Tumor Regression after Neoadjuvant Chemotherapy in Gastric Cancer, but Poor Survival of the Patient? Role of MHC Class I Alterations. Cancers. 2023; 15(3):771. https://doi.org/10.3390/cancers15030771

Hiltner, Theresa, Noémi Szörenyi, Meike Kohlruss, Alexander Hapfelmeier, Anna-Lina Herz, Julia Slotta-Huspenina, Moritz Jesinghaus, Alexander Novotny, Sebastian Lange, Katja Ott, and et al. 2023. "Significant Tumor Regression after Neoadjuvant Chemotherapy in Gastric Cancer, but Poor Survival of the Patient? Role of MHC Class I Alterations" Cancers 15, no. 3: 771. https://doi.org/10.3390/cancers15030771

Hiltner, T., Szörenyi, N., Kohlruss, M., Hapfelmeier, A., Herz, A.-L., Slotta-Huspenina, J., Jesinghaus, M., Novotny, A., Lange, S., Ott, K., Weichert, W., & Keller, G. (2023). Significant Tumor Regression after Neoadjuvant Chemotherapy in Gastric Cancer, but Poor Survival of the Patient? Role of MHC Class I Alterations. Cancers, 15(3), 771. https://doi.org/10.3390/cancers15030771